On the day that Warner Bros. Discovery's board announced its rejection of Paramount's latest bid, the David Ellison-led conglomerate took its argument to Capitol Hill. In a letter filed with a House Judiciary antitrust subcommittee on Wednesday, Paramount's chief legal officer, Makan Delrahim, wrote to lawmakers that the Netflix-WBD combination was “presumptively unlawful.

Analog Devices shares surge 35.7% in a year as AI-driven demand lifts industrial and communications growth, boosts data center sales and supports strong margins.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Varonis To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Varonis between February 4, 2025 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - January 9, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Varonis Systems, Inc. ("Varonis" …

Ford plans a $30,000 UEV platform with Level 3 eyes-off BlueCruise by 2028, aiming to deliver affordable highway autonomy.

ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.

Bristol Myers Squibb Company BMY has delivered a solid performance in recent months. The biotech major's shares have gained 17.3% over the past six months compared with the industry's growth of 23.4%.

TransMedics, KORU Medical Systems and Cardinal Health beat the S&P 500 as execution, earnings visibility and company-specific catalysts drove gains.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In F5 To Contact Him Directly To Discuss Their Options

LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gauzy Ltd. (“Gauzy” or “the Company”) (NASDAQ: GAUZ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Intuitive Surgical, Inc. dominates surgical robotics with an 80% global share and a robust, recurring-revenue business model anchored by the da Vinci platform. ISRG's installed base and procedure volumes continue double-digit growth, driven by superior clinical outcomes and high hospital switching costs. Despite premium valuation (forward P/E ~64), ISRG's pristine balance sheet, strong margins, and relentless innovation justify a long-term Buy rating.

Baidu edges ahead of Uber in the AV race, backed by global robotaxi rollout, stronger earnings outlook and valuation.

Evaluate the expected performance of Bank of America (BAC) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

General Motors (GM) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Besides Wall Street's top-and-bottom-line estimates for Home BancShares (HOMB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.

AtriCure (ATRC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evaluate the expected performance of Citigroup (C) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

The PNC Financial Services Group (PNC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Beyond analysts' top-and-bottom-line estimates for Wells Fargo (WFC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2025.

Casey's (CASY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.